| Application no. and date | 17176264.4 (espacenet) (Federated) (European Patent Register), 20100707 | | Patent/reg. no. and date | DK/EP 3252069, 20190403 | | Publication date | 20171206 | | Priority no. and date | DE 102009034362, 20090720 | | EP pub. no. and date |
EP 3252069 20171206 | | Effective date | | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | BBS BHC093030PCT-EP02 | | Inventor | Schwede, Wolfgang, Bayer Pharma AG
Magdeburger Str. 41a
16548 Glienicke, DE,
Klar, Ulrich, Bayer Pharma AG
Isegrimsteig 8a
13503 Berlin, DE,
Möller, Carsten, Gaillardstr. 14B
13187 Berlin, DE,
Rotgeri, Andrea, Bayer Pharma AG
Damwildsteig 21
13503 Berlin, DE,
Bone, Wilhelm, Bayer Pharma AG
Drewitzer Str. 46
13467 Berlin, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/567 (2006.01) , A61K 31/573 (2006.01) , A61P 5/36 (2006.01) , C07J 31/00 (2006.01) , C07J 41/00 (2006.01) | | Title | (11.BETA.,17.BETA.)-17-HYDROXY-11-[4-(METHYLSULFONYL)PHENYL]-17-(PENTALFUOROMETHYL)ESTRA-4,9-DIEN-3-ONER TIL BEHANDLING AF SYGDOMME | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
